Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Special cells can help regrow hair in alopecia areata.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Co-trimoxazole may help treat autoimmune diseases.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Ciproterone acetate improves hair regrowth and acne in most female patients.

GPC1 is important for hair growth by helping blood vessels form around hair follicles.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Most patients improved with oral contraceptives, but some needed additional treatment.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

CG2001 is safe and well-tolerated for treating hair loss in men.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.